Rayner Acquires This AG, Maker of Sophi Phaco Machines

Rayner announced that it has entered into a definitive agreement to acquire Swiss-based This AG, the inventor, developer and manufacturer of Sophi phaco emulsification machines.

Financial terms of the deal were not disclosed.

The acquisition marks a new chapter for Rayner as it branches out from its IOL portfolio to include phaco technology. According to Rayner, with advanced features including triple pump fluidics, active IOP control, clean venturi and day cassette, cable free power supply and wireless communication, Sophi (Swiss Ophthalmology Innovation) presents a truly advanced surgical system.

“The phaco machine plays a central role in cataract surgery. At Rayner, we aspire to launch the highest quality products, inspired by surgeons and driven by science. Sophi shares this vision, and their machines are truly differentiated with breakthrough technology combined with stunning design which makes them such a good fit for Rayner. I’m excited about their product range today, as well as what we will be planning together for tomorrow," Tim Clover, CEO of Rayner CEO, said in a company news release.

Rayner says the acquisition will enhance the company's range of products for cataract surgery, encompassing IOLs, OVDs, eye drops, pharmaceuticals, digital tools, and single-use recyclable instruments. 

"Sophi has been my primary phaco machine for the last 3 years and I would highly recommend it to fellow high-volume premium cataract and refractive surgeons. I have found its superior fluidics, ease of use and in-field support from the manufacturer to be highly differentiated,” said Erik L. Mertens, MD, FEBO, PCEO, FWCRS, Founder and Medical Director Medipolis Eye Centre.

The acquisition closed January 17, 2024.